Consolidated Statements of Shareholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Cumulative Effect, Period of Adoption, Adjusted Balance	Common Stock	Common Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjusted Balance	Treasury Stock	Treasury Stock Cumulative Effect, Period of Adoption, Adjusted Balance	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Retained Earnings Cumulative Effect, Period of Adoption, Adjusted Balance	Accumulated Other Comprehensive (Loss) Gain	Accumulated Other Comprehensive (Loss) Gain Cumulative Effect, Period of Adoption, Adjusted Balance
Beginning Balance (in shares) at Feb. 02, 2019				116,949	116,949			41,297	41,297
Beginning Balance at Feb. 02, 2019	$ 579,964	$ (1,287)	$ 578,677	$ 1,169	$ 1,169	$ 486,406	$ 486,406	$ (494,395)	$ (494,395)	$ 587,145	$ (1,287)	$ 585,858	$ (361)	$ (361)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(12,754)									(12,754)
Unrealized gain (losses) on marketable securities, net of taxes	200												200
Foreign currency translation adjustment	(267)												(267)
Issuance of common stock (in shares)				1,926
Issuance of common stock	1,143			$ 19		1,124
Dividends on common stock	(41,502)									(41,502)
Repurchase of common stock & tax withholdings related to share-based awards (in shares)				(457)
Repurchase of common stock & tax withholdings related to share-based awards	(2,550)			$ (4)		(2,546)
Share-based compensation	7,145					7,145
Ending Balance (in shares) at Feb. 01, 2020				118,418	118,418			41,297	41,297
Ending Balance at Feb. 01, 2020	530,092	$ (838)	$ 529,254	$ 1,184	$ 1,184	492,129	$ 492,129	$ (494,395)	$ (494,395)	531,602	$ (838)	$ 530,764	(428)	$ (428)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(360,144)									(360,144)
Unrealized gain (losses) on marketable securities, net of taxes	(88)												(88)
Foreign currency translation adjustment	580												580
Issuance of common stock (in shares)				1,759
Issuance of common stock	412			$ 18		394
Dividends on common stock	(10,855)									(10,855)
Repurchase of common stock & tax withholdings related to share-based awards (in shares)				(442)
Repurchase of common stock & tax withholdings related to share-based awards	(1,140)			$ (5)		(1,135)
Share-based compensation	7,100					7,100
Ending Balance (in shares) at Jan. 30, 2021				119,735				41,297
Ending Balance at Jan. 30, 2021	165,119			$ 1,197		498,488		$ (494,395)		159,765			64
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	46,218									46,218
Unrealized gain (losses) on marketable securities, net of taxes	(64)												(64)
Foreign currency translation adjustment	0
Issuance of common stock (in shares)				3,264
Issuance of common stock	64			$ 33		31
Dividends on common stock	37									37
Repurchase of common stock & tax withholdings related to share-based awards (in shares)				(473)
Repurchase of common stock & tax withholdings related to share-based awards	(1,904)			$ (5)		(1,899)
Share-based compensation	12,034					12,034
Ending Balance (in shares) at Jan. 29, 2022				122,526				41,297
Ending Balance at Jan. 29, 2022	$ 221,504			$ 1,225		$ 508,654		$ (494,395)		$ 206,020			$ 0